Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Lexaria BioscienceLEXX | Open-market buy | 25/07/29–25/07/30 | 25/07/30 | 27,500 sh2 trades | $0.92avg. | $25,181 | +10.8% | |
Lexaria BioscienceLEXX | Open-market buy | 25/07/29 | 25/07/30 | 15,000 sh | $0.91 | $13,650 | +30.0% | |
John Martin DochertyPresident & CSO | Lexaria BioscienceLEXX | Open-market buy | 25/07/29 | 25/07/30 | 5,376 sh | $0.93 | $4,999.68 | No record |
William Edward McKechnieDirector | Lexaria BioscienceLEXX | Open-market buy | 25/07/29 | 25/07/30 | 5,000 sh | $0.91 | $4,550 | +37.9% |
Vanessa CarleSecretary | Lexaria BioscienceLEXX | Open-market buy | 25/07/29 | 25/07/30 | 750 sh | $0.91 | $682.5 | No record |
Lexaria BioscienceLEXX | Open-market buy | 24/12/02–24/12/03 | 24/12/03 | 50,000 sh2 trades | $2.36avg. | $118,249.56 | No record | |
Catherine C. TurkelDirector | Lexaria BioscienceLEXX | Open-market buy | 24/08/12 | 24/08/13 | 1,600 sh | $3.13 | $5,008 | +106.7% |
Vanessa CarleSecretary | Lexaria BioscienceLEXX | Open-market sale | 24/07/31 | 24/08/01 | 2,567 sh | $4.00 | $10,268 | −100.0% |
Catherine C. TurkelDirector | Lexaria BioscienceLEXX | Open-market buy | 23/02/09 | 23/02/27 | 1,500 sh | $2.84 | $4,260 | No record |